Haemonetics 2nd Quarter and First Half Fiscal 2020 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 2nd Quarter and First Half Fiscal 2020 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) Tops Q2 EPS by 18c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus

November 1, 2019 6:10 AM EDT

Haemonetics (NYSE: HAE) reported Q2 EPS of $0.87, $0.18 better than the analyst estimate of $0.69. Revenue for the quarter came in at $253 million versus the consensus estimate of $249.77 million.

2Q20 Earnings... More